Founded in 2023, AltiusHub is a supply chain visibility software designed to help manufacturing companies safeguard their supply chains. In...

The early-stage firm will start deploying the fund in a quarter or 3-4 four months from now. The fund will focus on deeptech, health, softw...

Achieving high resilient growth while ensuring sustainable and inclusive livelihood options for all remains a priority for India. The inter...

Limitless potential for future global advancements in gene therapies is originating from India, said Dr David Gamm.

Startup founders, CEOs and policymakers stress on the need to reassess biz plans, valuation expectations amid funding woes. Companies with ...

Around this time last year, Facebook – the world’s biggest social media company – decided to change course and rename itself Meta. Twelve m...

The awards were tightly contested, demonstrating a pipeline of innovation and enterprise that is steadily improving the economy's productiv...

This year’s meeting took place against the backdrop of widespread turmoil across public and private markets, which has slashed the valuatio...

Eyestem’s aim to treat “incurable” eye diseases helped it pip Haber, an artificial intelligence powered startup that simplifies manufacturi...

The winners of the 2022 edition of the Economic Times Startup Awards, which recognise and celebrate excellence in the Indian startup ecosys...

Investors have largely been risk-averse when it comes to deep-funding biotech startups that have the potential to turn into billion-dollar ...

C-CAMP is one of the largest biotech ecosystems in India and a global hub for innovations led by deep-tech.

upGrad and Clevertap raised a combined $315 million this week.

The investment will enable Eyestem to progress a treatment for Dry Age-related Macular Degeneration to the clinic.

Existing investors Endiya Partners and Kotak Private Equity also participated in this round, valuing Eyestem at $46.4 million (INR 371 Cror...

Cell and gene therapy can go a long way in treating incurable diseases, but currently it is very pricey. Eyestem wants to dramatically cut ...

A new set of deep science startups is delving into subjects as diverse as medicine, energy and agri to lay the foundation for a large biote...